Patents by Inventor Hadar Lev-Tov

Hadar Lev-Tov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Wound monitoring sensors and use thereof
    Patent number: 11076786
    Abstract: The subject invention provides sensor systems that can detect biomarkers related to wound healing (e.g., uric acid, adenosine, arginine and/or xanthine). In one embodiment, the subject invention pertains to materials and methods for monitoring biomarkers non-invasively in a wound and a biofluid (e.g., sweat) in the proximity of the wound, optionally, including other physiological fluids. Skin based, non-invasive enzymatic electrochemical biosensor on a wearable platform (e.g., sweat patch) that can evaluate the healing of wounds through assessment of its biomarker levels are provided. This non-invasive detection from physiologically biofluids can reduce or eliminate occlusion effects.
    Type: Grant
    Filed: October 1, 2019
    Date of Patent: August 3, 2021
    Assignees: THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES, UNIVERSITY OF MIAMI
    Inventors: Sohini Roy Choudhury, Yogeswaran Umasankar, Shekhar Bhansali, Robert S. Kirsner, Hadar A. Lev-Tov
  • WOUND MONITORING SENSORS AND USE THEREOF
    Publication number: 20200100711
    Abstract: The subject invention provides sensor systems that can detect biomarkers related to wound healing (e.g., uric acid, adenosine, arginine and/or xanthine). In one embodiment, the subject invention pertains to materials and methods for monitoring biomarkers non-invasively in a wound and a biofluid (e.g., sweat) in the proximity of the wound, optionally, including other physiological fluids. Skin based, non-invasive enzymatic electrochemical biosensor on a wearable platform (e.g., sweat patch) that can evaluate the healing of wounds through assessment of its biomarker levels are provided. This non-invasive detection from physiologically biofluids can reduce or eliminate occlusion effects.
    Type: Application
    Filed: October 1, 2019
    Publication date: April 2, 2020
    Applicant: THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES
    Inventors: SOHINI ROY CHOUDHURY, YOGESWARAN UMASANKAR, SHEKHAR BHANSALI, ROBERT S. KIRSNER, HADAR A. LEV-TOV
  • Methods for in vitro inhibition of fibroblast proliferation
    Patent number: 9861832
    Abstract: Methods for LED generated low-level light therapy (LLLT) in the red, blue, and IR ranges are described to effectively inhibit fibroblast proliferation in vitro without altering viability, and may be used as therapy for the treatment of scars and other proliferative skin diseases.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: January 9, 2018
    Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
    Inventors: Jared Jagdeo, Roslyn Rivkah Isseroff, Andrew Mamalis, Neil Brody, Daniel Siegel, Hadar Lev-Tov
  • METHODS FOR IN VITRO INHIBITION OF FIBROBLAST PROLIFERATION
    Publication number: 20140277293
    Abstract: Methods for LED generated low-level light therapy (LLLT) in the red, blue, and IR ranges are described to effectively inhibit fibroblast proliferation in vitro without altering viability, and may be used as therapy for the treatment of scars and other proliferative skin diseases.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicants: THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Jared Jagdeo, Roslyn Rivkah Isseroff, Andrew Mamalis, Neil Brody, Daniel Siegel, Hadar Lev-Tov